X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse J.B.Chemicals with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ACTAVIS (US) - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 J.B.CHEMICALS   ACTAVIS
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
ACTAVIS
Dec-14
J.B.CHEMICALS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs31819,451-   
Low Rs20011,864-   
Sales per share (Unadj.) Rs148.03,502.5-  
Earnings per share (Unadj.) Rs19.1-437.1-  
Cash flow per share (Unadj.) Rs23.9321.3-  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.97,596.8-  
Shares outstanding (eoy) m84.82265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.5 39.1%   
Avg P/E ratio x13.6-35.8 -37.9%  
P/CF ratio (eoy) x10.848.7 22.2%  
Price / Book Value ratio x2.02.1 97.4%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9514,163,324 0.5%   
No. of employees `0002.721.6 12.7%   
Total wages/salary Rs m1,8410-   
Avg. sales/employee Rs Th4,590.943,116.7 10.6%   
Avg. wages/employee Rs Th673.40-   
Avg. net profit/employee Rs Th592.1-5,380.5 -11.0%   
INCOME DATA
Net Sales Rs m12,551931,321 1.3%  
Other income Rs m542-2,324 -23.3%   
Total revenues Rs m13,093928,996 1.4%   
Gross profit Rs m2,055119,641 1.7%  
Depreciation Rs m412201,665 0.2%   
Interest Rs m9629,376 0.3%   
Profit before tax Rs m2,088-113,724 -1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-8,342 0.0%   
Tax Rs m469-5,847 -8.0%   
Profit after tax Rs m1,619-116,219 -1.4%  
Gross profit margin %16.412.8 127.4%  
Effective tax rate %22.55.1 436.9%   
Net profit margin %12.9-12.5 -103.3%  
BALANCE SHEET DATA
Current assets Rs m7,778490,687 1.6%   
Current liabilities Rs m4,358357,855 1.2%   
Net working cap to sales %27.214.3 191.0%  
Current ratio x1.81.4 130.2%  
Inventory Days Days5558 94.2%  
Debtors Days Days8066 120.7%  
Net fixed assets Rs m5,713113,724 5.0%   
Share capital Rs m1700-   
"Free" reserves Rs m10,5470-   
Net worth Rs m10,9372,020,000 0.5%   
Long term debt Rs m01,058,520 0.0%   
Total assets Rs m15,5743,701,996 0.4%  
Interest coverage x22.8-2.9 -794.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.80.3 320.4%   
Return on assets %11.0-2.3 -469.3%  
Return on equity %14.8-5.8 -257.2%  
Return on capital %20.0-3.0 -663.1%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Net fx Rs m4,8840-   
CASH FLOW
From Operations Rs m1,397159,926 0.9%  
From Investments Rs m-320-382,924 0.1%  
From Financial Activity Rs m-1,196215,148 -0.6%  
Net Cashflow Rs m-102-7,850 1.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.3 Rs / USD

Compare J.B.CHEMICALS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare J.B.CHEMICALS With: SHASUN PHARMA  NATCO PHARMA  GLENMARK PHARMA  PFIZER  TTK HEALTHCARE  



Today's Market

Sensex Ends 274 Points Lower; IT and Energy Stocks Witness Selling(Closing)

Share markets in India continued to witness selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Nov 21, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - IPCA LABS COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS